FusionBio, Inc. is a biopharmaceutical company based in Chapel Hill, NC, specializing in the development of innovative treatments for immune mediated diseases such as cancer and autoimmunity.
With their unique FusionBio technology, they offer a distinct advantage by generating stable covalent trimers of tumor necrosis factor superfamily ligands, which can be used alone or in combination with other immunotherapy agents, without the need for external additions or the risk of introducing immunogenicity problems.
Generated from the website